{"name": "Cantab Biopharmaceuticals",
 "permalink": "cantab-biopharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/cantab-biopharmaceuticals",
 "homepage_url": "http://www.cantabbio.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@cantabbio.com",
 "phone_number": "+44 (0)1223 423 413 ",
 "description": "",
 "created_at": "Tue Jan 26 05:45:26 UTC 2010",
 "updated_at": "Tue Jan 26 08:53:42 UTC 2010",
 "overview": "\u003Cp\u003ECantab Biopharmaceuticals Ltd is a drug development company focused on the development of \u0026#8220;biosuperior\u0026#8221; products. Based on Cambridge Science Park, Cantab is at the heart of the largest biotech cluster in Europe.\u003C/p\u003E\n\n\u003Cp\u003ECantab is using it\u0026#8217;s extensive experience in biopharmaceutical discovery, process development and GMP manufacturing to expedite the development of biosuperiors from inception through clinical development.\u003C/p\u003E\n\n\u003Cp\u003EPreviously marketed, off-patent, biologics will be enhanced by the application of appropriate cutting-edge technologies in protein expression/engineering, process/manufacturing technology, protein conjugation, formulation and drug delivery.\u003C/p\u003E\n\n\u003Cp\u003EParticular areas of drug characteristics that Cantab seek to improve upon are product presentation and stability, pharmacokinetics, pharmacodynamics, immunogenicity and drug delivery.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       52],
      "assets/images/resized/0007/4839/74839v1-max-150x150.png"],
     [[190,
       67],
      "assets/images/resized/0007/4839/74839v1-max-250x250.png"],
     [[190,
       67],
      "assets/images/resized/0007/4839/74839v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Jim",
      "last_name": "Mills",
      "permalink": "jim-mills-2",
      "image": null}},
   {"is_past": false,
    "title": "Finance \u0026 HR Manager",
    "person":
     {"first_name": "Victoria",
      "last_name": "Allen",
      "permalink": "victoria-allen",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$8.1M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020100125e61q000rt\u0026r=Rss\u0026s=DJFVW",
    "source_description": "Cantab Biopharma Gathers $8.1M From Celtic Pharma Holdings",
    "raised_amount": 8100000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 25,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Celtic Pharma",
         "permalink": "celtic-pharma",
         "image":
          {"available_sizes":
            [[[150,
               73],
              "assets/images/resized/0006/1929/61929v2-max-150x150.jpg"],
             [[150,
               73],
              "assets/images/resized/0006/1929/61929v2-max-250x250.jpg"],
             [[150,
               73],
              "assets/images/resized/0006/1929/61929v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "155 Cambridge Science Park",
    "address2": "Milton Road",
    "zip_code": "CB4 0GN",
    "city": "Cambridge",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}